Please note: these data are *not* the property of the authors. These are values extracted from either the figures and tables of each reference or from the systematic reviews by Bond et al. (2012) and Loveman et al. (2006) for the purpose of meta-analysis. Standard deviation of change was calculated in the case that the standard error of mean change was given with group sample sizes. [1] Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, et al. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of TA111): a systematic review and economic model. Health Technol Assess 2012;16(21) [2] Loveman E, Green C, Kirby J, et al. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Health Technol Assess 2006;10:1–160